Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism
NCT04246073
·
clinicaltrials.gov ↗
UNKNOWN
Status
400
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Cancer Diagnosis
Thromboembolism
Sponsor
Hellenic Society of Surgical Oncology